- Home
- NXPLW vs INM Comparison
NXPLW vs INM Comparison
Compare NXPLW & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPLW
- INM
- Stock Information
- Founded
- NXPLW N/A
- INM 1981
- Country
- NXPLW United States
- INM Canada
- Employees
- NXPLW 166
- INM N/A
- Industry
- NXPLW Telecommunications Equipment
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- NXPLW Telecommunications
- INM Health Care
- Exchange
- NXPLW Nasdaq
- INM Nasdaq
- Market Cap
- NXPLW N/A
- INM N/A
- IPO Year
- NXPLW N/A
- INM N/A
- Fundamental
- Price
- NXPLW $0.15
- INM $3.00
- Analyst Decision
- NXPLW
- INM
- Analyst Count
- NXPLW 0
- INM 0
- Target Price
- NXPLW N/A
- INM N/A
- AVG Volume (30 Days)
- NXPLW 6.4K
- INM 55.2K
- Earning Date
- NXPLW 03-31-2025
- INM 05-13-2025
- Dividend Yield
- NXPLW N/A
- INM N/A
- EPS Growth
- NXPLW N/A
- INM N/A
- EPS
- NXPLW N/A
- INM N/A
- Revenue
- NXPLW $66,482,000.00
- INM $4,832,013.00
- Revenue This Year
- NXPLW N/A
- INM N/A
- Revenue Next Year
- NXPLW N/A
- INM N/A
- P/E Ratio
- NXPLW N/A
- INM N/A
- Revenue Growth
- NXPLW 179.89
- INM N/A
- 52 Week Low
- NXPLW $0.25
- INM $1.72
- 52 Week High
- NXPLW $0.26
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- NXPLW N/A
- INM 61.34
- Support Level
- NXPLW N/A
- INM $2.56
- Resistance Level
- NXPLW N/A
- INM $3.15
- Average True Range (ATR)
- NXPLW 0.00
- INM 0.26
- MACD
- NXPLW 0.00
- INM 0.10
- Stochastic Oscillator
- NXPLW 0.00
- INM 89.51
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.